XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Preferred Stock
Common Stock
Additional Paid-In Capital
Retained Earnings
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2021   0        
Beginning balance at Dec. 31, 2021 $ 235,910 $ 0 $ 134 $ 114,017 $ 130,103 $ (8,344)
Beginning balance (in shares) at Dec. 31, 2021     13,394      
Beginning balance (in shares) at Dec. 31, 2021           775
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Compensation expense on common stock options 21     21    
Issuance of restricted stock (in shares)     79      
Compensation expense on restricted common stock 402   $ 1 401    
Taxes paid related to net shares settlement of equity awards (359)     (359)    
Purchase of treasury shares (in shares)           247
Purchase of treasury shares (2,928)         $ (2,928)
Net income 337       337  
Ending balance (in shares) at Mar. 31, 2022   0        
Ending balance at Mar. 31, 2022 233,383 $ 0 $ 135 114,080 130,440 $ (11,272)
Ending balance (in shares) at Mar. 31, 2022     13,473      
Ending balance (in shares) at Mar. 31, 2022           1,022
Beginning balance (in shares) at Dec. 31, 2021   0        
Beginning balance at Dec. 31, 2021 235,910 $ 0 $ 134 114,017 130,103 $ (8,344)
Beginning balance (in shares) at Dec. 31, 2021     13,394      
Beginning balance (in shares) at Dec. 31, 2021           775
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 267          
Ending balance (in shares) at Jun. 30, 2022   0        
Ending balance at Jun. 30, 2022 229,756 $ 0 $ 135 114,255 130,370 $ (15,004)
Ending balance (in shares) at Jun. 30, 2022     13,499      
Ending balance (in shares) at Jun. 30, 2022           1,310
Beginning balance (in shares) at Mar. 31, 2022   0        
Beginning balance at Mar. 31, 2022 233,383 $ 0 $ 135 114,080 130,440 $ (11,272)
Beginning balance (in shares) at Mar. 31, 2022     13,473      
Beginning balance (in shares) at Mar. 31, 2022           1,022
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Compensation expense on common stock options 147     147    
Issuance of restricted stock (in shares)     26      
Compensation expense on restricted common stock 184   $ 0 184    
Taxes paid related to net shares settlement of equity awards (156)     (156)    
Purchase of treasury shares (in shares)           288
Purchase of treasury shares (3,732)         $ (3,732)
Net income (70)       (70)  
Ending balance (in shares) at Jun. 30, 2022   0        
Ending balance at Jun. 30, 2022 $ 229,756 $ 0 $ 135 114,255 130,370 $ (15,004)
Ending balance (in shares) at Jun. 30, 2022     13,499      
Ending balance (in shares) at Jun. 30, 2022           1,310
Beginning balance (in shares) at Dec. 31, 2022 0 0        
Beginning balance at Dec. 31, 2022 $ 230,076 $ 0 $ 135 115,411 129,534 $ (15,004)
Beginning balance (in shares) at Dec. 31, 2022     13,519      
Beginning balance (in shares) at Dec. 31, 2022 1,310         1,310
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Compensation expense on common stock options $ 22     22    
Issuance of restricted stock (in shares)     29      
Compensation expense on restricted common stock 465     465    
Taxes paid related to net shares settlement of equity awards (184)     (184)    
Net income 370       370  
Ending balance (in shares) at Mar. 31, 2023   0        
Ending balance at Mar. 31, 2023 $ 230,749 $ 0 $ 135 115,714 129,904 $ (15,004)
Ending balance (in shares) at Mar. 31, 2023     13,548      
Ending balance (in shares) at Mar. 31, 2023           1,310
Beginning balance (in shares) at Dec. 31, 2022 0 0        
Beginning balance at Dec. 31, 2022 $ 230,076 $ 0 $ 135 115,411 129,534 $ (15,004)
Beginning balance (in shares) at Dec. 31, 2022     13,519      
Beginning balance (in shares) at Dec. 31, 2022 1,310         1,310
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income $ 874          
Ending balance (in shares) at Jun. 30, 2023 0 0        
Ending balance at Jun. 30, 2023 $ 231,585 $ 0 $ 136 116,045 130,408 $ (15,004)
Ending balance (in shares) at Jun. 30, 2023     13,688      
Ending balance (in shares) at Jun. 30, 2023 1,310         1,310
Beginning balance (in shares) at Mar. 31, 2023   0        
Beginning balance at Mar. 31, 2023 $ 230,749 $ 0 $ 135 115,714 129,904 $ (15,004)
Beginning balance (in shares) at Mar. 31, 2023     13,548      
Beginning balance (in shares) at Mar. 31, 2023           1,310
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Compensation expense on common stock options 30     30    
Issuance of restricted stock (in shares)     140      
Issuance of restricted stock 0   $ 1 (1)    
Compensation expense on restricted common stock 1,100     1,100    
Taxes paid related to net shares settlement of equity awards (798)     (798)    
Net income $ 504       504  
Ending balance (in shares) at Jun. 30, 2023 0 0        
Ending balance at Jun. 30, 2023 $ 231,585 $ 0 $ 136 $ 116,045 $ 130,408 $ (15,004)
Ending balance (in shares) at Jun. 30, 2023     13,688      
Ending balance (in shares) at Jun. 30, 2023 1,310         1,310